Trial intelligence / Profile preview

Duloxetine for primary frozen shoulder pain

ChiCTR2100047183Phase 4Recruiting

Sponsor
Tianjin Medical University General Hospital
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of duloxetine in adhesive capsulitis (AC) (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoint: Visual analogue scale at 12 weeks. Started Jun 2021; status: recruiting.

02

Drugs

duloxetine
03

Conditions

adhesive capsulitis (AC)

Beyond the preview

Go deeper on ChiCTR2100047183.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047183.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call